Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance.
about
P1343
HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss.Molecular classifications of gastric cancers: Novel insights and possible future applications.Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathwayTissue transglutaminase-1 promotes stemness and chemoresistance in gastric cancer cells by regulating Wnt/β-catenin signaling.Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance.PTEN loss is associated with a poor response to trastuzumab in HER2-overexpressing gastroesophageal adenocarcinoma.Expression of ERO1L in gastric cancer and its association with patient prognosisActionable gene-based classification toward precision medicine in gastric cancer.In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction.Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.Proposed Molecular and miRNA Classification of Gastric Cancer.
P2860
Q33626569-95A655DA-BE10-4D6D-898F-4EB72EF2C861Q33696201-82873857-721A-4A4A-9A11-83784D7A7ACAQ37109776-B25DA0A3-E289-4BAB-9EDA-D2641BF5586DQ37224355-06443AF7-1362-499B-8C3E-87906704E38FQ37514770-C42D414C-68EB-4BDA-95BA-18662CD7BBE7Q38703402-9C1E551E-6FBA-4A02-8800-42C50A2C2800Q38752291-4AF18EF4-B8D8-4272-AE75-C61F895468DEQ41672431-1F3D88A4-5E5B-460C-BF4F-0042E4DF305CQ47113548-4E5F52B1-2FF6-40D8-A633-9DE091CC1D5DQ49875087-524D5E0B-B143-4D99-BE44-A3CA57D86827Q49887912-245F988E-B085-4587-A53C-202E334C8177Q52657273-DDCDFDC0-7010-4037-846B-763F71935807Q55603677-E6816691-D102-441A-BCE1-DC5E2C046610
P2860
Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Development of trastuzumab-res ...... mechanisms of drug resistance.
@en
type
label
Development of trastuzumab-res ...... mechanisms of drug resistance.
@en
prefLabel
Development of trastuzumab-res ...... mechanisms of drug resistance.
@en
P2093
P2860
P356
P1433
P1476
Development of trastuzumab-res ...... mechanisms of drug resistance.
@en
P2093
Jingwen Zhang
Lihong Guo
Mengwan Wu
Wangjun Liao
P2860
P2888
P356
10.1038/SREP11634
P407
P4510
P577
2015-06-25T00:00:00Z
P5875
P6179
1048458593